Clinical Trials Logo
  1. Home
  2. Tourette's Disorder
  3. NCT01727713

Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Tourette's Disorder Clinical Trial

Official title:
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Clinical Trial Summary

The goal of the current trial is to determine safety of Once-daily aripiprazole in reducing Total Tic Severity in children and adolescents with Tourette's Disorder.

Clinical Trial Description

Tourette's Disorder is a neuropsychiatric condition that is characterized by the appearance of tics that can be simple or complex in nature. A tic is a sudden, rapid, recurrent, non-rhythmic, stereotyped motor movement or vocalization. There are a very limited number of medications approved for the treatment of Tourette's Disorder. The goal of the current trial is to obtain additional efficacy, safety, and tolerability data in a controlled condition of a Once-daily aripiprazole formulation in children and adolescents with Tourette's Disorder. The trial is a 52-week extension to the double-blind trial.

The Once-daily tablet formulation that will be evaluated in this trial represents a daily dosage regimen that is intended to be administered to children and adolescents. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01727713
Study type Interventional
Source Otsuka Pharmaceutical Development & Commercialization, Inc.
Contact
Status Completed
Phase Phase 3
Start date January 2013
Completion date September 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT02316145 - Internet-based Coaching for Young Adults With Neuropsychiatric Disorders N/A
Completed NCT00706589 - Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder Phase 3
Completed NCT01416441 - Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Completed NCT01727700 - Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Recruiting NCT06408662 - Remote Delivery of a Mindfulness-based Intervention for Tics N/A
Completed NCT01315327 - Omega-3 Fatty Acids in Tourette's Disorder N/A
Completed NCT01795105 - ABF Tourette's Disorder Post Marketing Surveillance Study
Completed NCT01418339 - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Completed NCT01585207 - Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder Phase 1/Phase 2
Completed NCT03042507 - Psychosocial Intervention for Young Children With Chronic Tics N/A
Completed NCT03508245 - Investigating Circadian Rhythms in Youth With Persistent Tic Disorders N/A
Completed NCT02864589 - Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder N/A
Completed NCT02413216 - TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT) N/A
Completed NCT01177774 - Assessment of Children With Tic Onset in the Past 6 Months
Completed NCT01418352 - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD) Phase 3
Recruiting NCT05499741 - Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder N/A
Completed NCT03916055 - Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder N/A